BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Bargains & Bubbles

The Frozen Market: What Home Depot’s Numbers Say About Housing’s Standoff

Moe Alsumidaie by Moe Alsumidaie
August 27, 2026
in Bargains & Bubbles
0
75
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

For most of its history, Home Depot has been a mirror held up to the American housing market. When rates fall and homes change hands, people renovate. When rates rise and nobody moves, they don’t. That relationship has never been more legible than right now, because the mirror is showing something strange: the store is still open, customers are still spending, and yet the big projects, the ones that signal genuine housing confidence, remain almost completely frozen.

Understanding why that matters requires a short detour into what Home Depot actually is. It’s the largest home-improvement retailer in the United States, which means it sits at the intersection of two enormous forces: what people earn and spend, and whether they feel confident enough about their homes to sink serious money into them. When those forces align, the company prints cash. When they pull apart, as they have since 2022, the numbers start telling a more complicated story.

In one breath

Home Depot’s filed numbers show a business that is growing again after a rare revenue decline in fiscal 2023, but its net margin has slipped from nearly eleven cents on every dollar of sales at the pandemic peak to less than nine cents today. Big-ticket purchases, the ones over a thousand dollars that signal real remodeling confidence, grew less than one percent in the most recent quarter, while overall customer traffic actually fell. The stock sits more than twenty percent below its fifty-two-week high, priced near its decade-median earnings multiple, which means the market is neither panicking nor celebrating. The open question is whether the housing market’s current standoff, high prices, high rates, and almost no turnover, lifts before the margin pressure becomes structural.

The pandemic renovation boom shows up as a spike; the 2022-2023 rate shock shows up as a stall. Recent growth near 3% reflects price and acquisitions more than a housing market that’s actually moving again. Interactive: hover for values. Official data via SEC EDGAR.

How we got here: the boom, the hangover, and the freeze

The pandemic turned Home Depot into something it had never quite been before: a growth story. With mortgage rates hitting a generational low in early 2021, Americans refinanced, bought homes, and immediately started tearing them apart. Fiscal 2021 revenue reached $151.2 billion, up fourteen percent in a single year. That’s the kind of growth a retailer of this size almost never sees.

BullScope TerminalHome Depot was the article. The engine is the product.Same yardsticks, any ticker: filed financials in, math-vs-mood out. Nothing here is advice; it is the evidence, organized.Run another company →

Then the Federal Reserve started raising rates. By late 2023, the thirty-year fixed mortgage rate had climbed past eight percent, a level not seen in a generation. Homeowners who had locked in pandemic-era rates had no reason to sell, so they didn’t. Buyers who needed to borrow at those elevated levels couldn’t afford to buy. The market froze. After fiscal 2022 pushed the top line to a peak of $157.4 billion, revenue fell to $152.7 billion in fiscal 2023, the first meaningful decline in years, and U.S. comparable sales dropped more than three percent. For a company whose fate is tied to housing turnover, a frozen market is about as bad as it gets.

The crisis of 2008 offers a useful reference point. Home Depot’s fiscal 2008 sales fell 7.8% as the housing market collapsed. The dynamic then was different, falling prices rather than frozen inventory, but the mechanism was the same: when people stop moving, they stop renovating at scale. The current freeze is quieter than 2008, but it has lasted longer than most expected.

The math today: growing, but thinner

The most recent complete fiscal year, fiscal 2025 ended February 1, 2026, shows revenue of $164.7 billion, up about three percent from the prior year. That sounds like recovery, and in volume terms it is. But the net margin, what’s left of each dollar of sales after every bill is paid, has compressed from nearly eleven percent at the peak to under nine percent today. In a business generating roughly a hundred and sixty-five billion dollars in sales, each percentage point of margin is worth more than a billion and a half dollars of profit. The compression is not trivial.

The most recent quarter, Q1 fiscal 2026 ended May 3, 2026, adds texture. Total sales reached $41.8 billion, up nearly five percent year-over-year, which looks healthy. But comparable-store sales, a cleaner measure that strips out new store openings and acquisitions, grew just 0.6%. Customer traffic actually fell. The average customer spent more per visit, which is what you’d expect when prices are elevated, but fewer customers came through the door. Big-ticket transactions were barely above flat. Management noted on the May 19 earnings call that underlying demand remained “relatively similar to what we saw throughout fiscal 2025,” alongside “greater consumer uncertainty and housing affordability pressure.” That’s a careful way of saying: nothing has broken, but nothing has healed either.

The gross margin, what’s left after the cost of the goods themselves, fell by nearly a full percentage point from a year earlier, partly because of the GMS acquisition, which added professional contractor supply but at lower margins than the core retail business. Scale can dilute as well as amplify.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: Home Depot and 500+ other names, on the same official data.See the evidence engine →

The rate lock and the record price

The housing data explains why the big-ticket freeze persists. As of the week ending July 16, 2026, the 30-year fixed mortgage rate averaged 6.55%, according to Freddie Mac’s Primary Mortgage Market Survey. That’s well below the 2023 peak, but still more than double where it sat during the pandemic boom. The Federal Reserve held its benchmark rate steady at its June 17, 2026 meeting, and futures markets as of late July price in a possible hike by year-end, not the cuts that would ease mortgage costs.

Meanwhile, the median existing-home price hit a record in June 2026, according to data cited by Zillow, even as existing-home sales fell from the prior month. Housing starts jumped sharply in June, which is encouraging for the new-construction side, but existing homes are where most of the remodeling demand lives, and that market remains effectively locked. A household that bought at three percent isn’t selling into six and a half. The math doesn’t work for them, so they stay put, and when they stay put, they don’t trigger the wave of renovation spending that typically follows a home sale.

This is the mechanism that matters for Home Depot. A home sale is almost always followed by spending: new paint, new appliances, a bathroom refresh. When sales stall, that spending stalls with them. The near-flat growth in big-ticket transactions captures this most directly. It’s not a collapse, but it’s not the recovery the business needs to rebuild its margins.

The mood vs. the math

Our data shows Home Depot’s price-to-earnings multiple, the price tag the market puts on each dollar of annual profit, sitting just above its decade median. That means the stock is priced close to normal, not cheap and not stretched. On a revenue basis, the stock looks relatively modest by its own history. The math (what the filed fundamentals show) and the mood (what the market is paying) are not far apart, which is unusual for a name this widely followed. The stock’s decline from its fifty-two-week high has brought the valuation back toward historical norms after a period when the mood ran well ahead of the math.

The tension isn’t between an expensive stock and a struggling business. It’s between a business that is clearly capable of much higher margins, as the pandemic years proved, and a housing environment that may not allow those margins to return until rates fall meaningfully or the existing-home market thaws. Those are two different clocks, and neither is under Home Depot’s control.

Reading the numbers

  • Net margin, 8.6% in fiscal 2025 vs. 10.9% in fiscal 2021. Net margin is what’s left of each dollar of sales after every cost, tax, and interest payment. At 10.9%, a business keeping nearly 11 cents of every dollar is performing well. At 8.6%, it’s keeping about 8.6 cents. On $165 billion of sales, that 2.That 2.3-point difference is roughly $3.8 billion of annual profit that existed at the peak and doesn’t today. Think of it as a household that used to save $109 of every $1,000 earned and now saves $86.
  • Comparable-store sales growth, 0.6% in Q1 fiscal 2026. This strips out new stores and acquisitions to show how existing locations are performing. At 0.6%, growth is barely above flat. A store doing $10 million in sales a year ago is doing about $10.06 million now. That’s not shrinking, but it’s not the 14% growth of fiscal 2021 either.
  • Big-ticket comparable transactions, up 0.8% in Q1 fiscal 2026. Purchases over $1,000 are the clearest signal of remodeling confidence, because a homeowner buying a new HVAC system or redoing a kitchen is making a multi-year commitment to a property. At 0.8% growth, this category is essentially flat. Compare that to the Q2 2025 reading of 2.6% positive, and the trend is moving in the wrong direction.
  • 30-year fixed mortgage rate, 6.55% as of July 16, 2026. This is what a household borrowing to buy a home pays annually on each dollar borrowed. At 6.55%, a $400,000 mortgage costs roughly $2,530 per month in principal and interest alone. At 3%, that same mortgage cost about $1,686. The $844 monthly difference is why millions of homeowners aren’t selling, and why Home Depot’s big-ticket category remains subdued.
  • P/E ratio, 23.9 vs. decade median of 23.3. The P/E ratio is the price tag per dollar of annual profit. At 23.9, the market is paying roughly $24 for every $1 Home Depot earns per year. That’s almost exactly what it has paid on average over the past decade, meaning neither a bargain nor a premium by the company’s own history.

For the standing yardsticks on Home Depot: the price tag, the filed record, and the four gauges, refreshed with each edition, see the BullScope Evidence Sheet: Home Depot.

Sources

  • Home Depot 10-Q, quarter ended May 3, 2026 (SEC EDGAR)
  • Home Depot 10-K, fiscal year ended February 1, 2026 (SEC EDGAR)
  • Home Depot 10-K, fiscal year ended January 28, 2024 (SEC EDGAR)
  • Home Depot Q4 2021 earnings press release
  • Home Depot Q1 2026 earnings call transcript, May 19, 2026
  • Home Depot fiscal 2008 earnings release, February 24, 2009
  • Freddie Mac Primary Mortgage Market Survey
  • Federal Reserve FOMC statement, June 17, 2026
  • Zillow mortgage rate and home price data
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read Home Depot’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie

Moe Alsumidaie

Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.

Recommended For You

Abbott’s Split Personality: Revenue Climbs 14%, the Stock Falls Anyway

by Moe Alsumidaie
October 22, 2026
0

Abbott Laboratories spent most of the pandemic era as a Wall Street darling, its COVID test sales turning a steady healthcare conglomerate into a growth story. Then the...

Read moreDetails

The $14 Acquisition Price and the Arbitrage Gap the Market Is Pricing

by Moe Alsumidaie
October 16, 2026
0

The short version Sun Pharmaceutical agreed in April 2026 to buy Organon for $14.00 a share in cash, a deal Organon shareholders approved in July. The stock trades...

Read moreDetails

From $8 to $0.45: Ascend Wellness Is Generating Real Cash While the Market Prices It for Failure

by Moe Alsumidaie
October 14, 2026
0

The story, briefly The math, meaning what the filed numbers actually show, tells a story of a cannabis retailer that turned cash-flow positive in 2023 and has been...

Read moreDetails

ADMA Biologics: A Business Earning Real Money, Priced Like It Might Not

by Moe Alsumidaie
October 13, 2026
0

Six years ago, ADMA Biologics was losing nearly two dollars for every dollar it brought in. The company made a single class of medicine, plasma-derived immunoglobulins (proteins collected...

Read moreDetails

Viatris: The Stock Has Run 72% in a Year. The Filed Numbers Tell a More Complicated Story.

by Moe Alsumidaie
October 9, 2026
0

The share price is up 72% over the past twelve months. Revenue has fallen every single year since 2021. Those two facts belong to the same company, and...

Read moreDetails
Next Post

JPMorgan at Its Own Ceiling: What a Record Quarter Tells Us About the Price Tag

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Evidence Sheet: Mcdonalds (MCD)

August 24, 2026

Walmart’s Math Says One Thing. The Price Tag Says Another.

August 3, 2026

Acadia Pharmaceuticals: A Business Turning Profitable Trades at a Discount to Its Own History

September 16, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.